MicroRNAs and Drug Addiction by Purva Bali & Paul J. Kenny
REVIEW ARTICLE
published: 10 May 2013
doi: 10.3389/fgene.2013.00043
MicroRNAs and drug addiction
Purva Bali 1,2 and Paul J. Kenny 1,2*
1 Laboratory of Behavioral and Molecular Neuroscience, Department of Molecular Therapeutics, The Scripps Research Institute – Florida, Jupiter, FL, USA
2 Laboratory of Behavioral and Molecular Neuroscience, Department of Neuroscience, The Scripps Research Institute – Florida, Jupiter, FL, USA
Edited by:
Andre Pietrzykowski, Rutgers
University, USA
Reviewed by:
Marissa A. Ehringer, University of
Colorado, USA
Hironori Kawahara, University of
Pennsylvania School of Medicine,
USA
*Correspondence:
Paul J. Kenny, Laboratory of
Behavioral and Molecular
Neuroscience, Department of
Molecular Therapeutics, The Scripps
Research Institute – Florida, 130
ScrippsWay, Jupiter, FL 33458, USA.
e-mail: pjkenny@scripps.edu
Drug addiction is considered a disorder of neuroplasticity in brain reward and cognition
systems resulting from aberrant activation of gene expression programs in response to
prolonged drug consumption. Non-coding RNAs (ncRNAs) are key regulators of almost all
aspects of cellular physiology. MicroRNAs (miRNAs) are small (∼21–23 nucleotides) ncR-
NAs transcripts that regulate gene expression at the post-transcriptional level. Recently,
miRNAs were shown to play key roles in the drug-induced remodeling of brain reward sys-
tems that likely drives the emergence of addiction. Here, we review evidence suggesting
that one particular miRNA, miR-212, plays a particularly prominent role in vulnerability to
cocaine addiction. We review evidence showing that miR-212 expression is increased in
the dorsal striatum of rats that show compulsive-like cocaine-taking behaviors. Increases in
miR-212 expression appear to protect against cocaine addiction, as virus-mediated striatal
miR-212 overexpression decreases cocaine consumption in rats. Conversely, disruption of
striatal miR-212 signaling using an antisense oligonucleotide increases cocaine intake. We
also review data that identify two mechanisms by which miR-212 may regulate cocaine
intake. First, miR-212 has been shown to amplify striatal cAMP response element binding
protein (CREB) signaling through a mechanism involving activation of Raf1 kinase. Second,
miR-212 was also shown to regulate cocaine intake by repressing striatal expression of
methyl CpG binding protein 2 (MeCP2), consequently decreasing protein levels of brain-
derived neurotrophic factor (BDNF). The concerted actions of miR-212 on striatal CREB
and MeCP2/BDNF activity greatly attenuate the motivational effects of cocaine.These find-
ings highlight the unique role for miRNAs in simultaneously controlling multiple signaling
cascades implicated in addiction.
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INTRODUCTION
Non-coding RNAs (ncRNAs) can be defined as biologically func-
tional RNAs that do not encode proteins. This class of transcripts
is characterized by the presence of an increased density of stop
codons and lack of extensive open reading frames (ORFs). For
decades, work on ncRNAs focused almost exclusively on trans-
port RNAs (tRNAs) and ribosomal RNAs (rRNAs), which are key
regulators of mRNA translation into encoded proteins. However,
recent advances in high throughput sequencing technologies have
revealed tremendous diversity in ncRNAs. Moreover, ncRNAs are
playing an increasingly more recognized role in key aspects of
cellular function, including the regulation of gene expression,
often through novel mechanisms of action. ncRNAs have also
been implicated in key cellular process such as DNA imprint-
ing, RNA splicing, editing, transcription, mRNA degradation, and
translational repression. Interestingly, analysis of ncRNA complex-
ity through evolution reveals that the proportion of non-coding
sequences in eukaryotic genomes correlates closely with the com-
plexity of the organism, even when proportion of the protein
coding genes remains relatively static across organisms (Heimberg
et al., 2008).
It is currently thought that only about 2% of the human genome
codes for functional proteins, yet more than 80% of transcripts
encoded in the genome may have some biochemical activity. In a
recent study, Djebali et al. (2012) used ultra-deep sequencing of
RNAs from different cell lines and concluded that ∼75% of the
genome is transcribed at some point during the cellular life cycle.
These extensive studies using sequencing and sophisticated ncRNA
prediction algorithms have led to the identification of thousands
of ncRNAs in the human genome, and perhaps many more remain
to be discovered (Majer and Booth, 2010; Yang et al., 2010).
On the basis of their length and function this heteroge-
neous group of transcripts can be further categorized into short
ncRNAs and long ncRNAs. The short ncRNAs include microR-
NAs (miRNAs) and short-interfering RNAs (siRNAs), which are
generally 18–25 nucleotides in length. Small RNAs (smRNAs)
such as the small nucleolar RNAs (snoRNAs), smRNAs, piwi-
interacting RNA (piRNAs) are between 20 and 300 nucleotides
in length. The long ncRNAs (>200 nucleotides) can further be
grouped into different categories on the basis of their origin
(Orom and Shiekhattar, 2011) and have a broader spectrum of
functions including chromatin modulation, recruitment of tran-
scription factors, and nuclear-cytoplasmic transport (Mattick and
Makunin, 2006). Indeed, there is now compelling computational
and experimental evidence that many previously uncharacterized
ncRNAs of unknown function, considered largely “transcriptional
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noise,” have key functional roles in almost all aspects of cellular
physiology.
Using the high throughput in situ expression data from Allen
Brain Atlas, Mercer et al. have recently shown that more than 800
different ncRNAs are widely expressed in the adult brain (Mercer
et al., 2008). In another study, Landgraf et al. created a miRNA
expression atlas by sequencing and analyzing multiple smRNAs
libraries (Landgraf et al., 2007). Their data also reveals a tissue/cell
specific expression of these RNAs, which correlates with in situ
expression data. Hence, it is likely that ncRNAs play an important
role in basic aspects of brain function and behavior.
MicroRNAs IN BRAIN
Amongst the different classes of ncRNAs, miRNAs are perhaps
the best characterized. Since their discovery in C. elegans in
1993 (Lee et al., 1993), hundreds of miRNAs have been identi-
fied in different species. Initial studies demonstrated that these
short (∼22 nucleotide) RNAs are mainly involved in binding to
the 3′ untranslated region (3′UTR) of mRNA transcripts that
share complementarity with nucleotides in their so-called seed
sequence (nucleotides 2–7). Binding of miRNAs to mRNA tran-
scripts results in post-transcription silencing of the target mRNA
via RNA-induced silencing complex (RISC)-induced translational
repression or sequestering them for storage or degradation (Bartel,
2004). However, emerging new evidence suggests that the non-
seed region of miRNAs may bind to the 5′UTR or the coding
sequence of target transcripts and thereby influence translation
processes (Orom et al., 2008; Elcheva et al., 2009). To add further
complexity, recent reports show that miRNAs can also positively
regulate gene expression in some cellular contexts (Vasudevan
et al., 2007; Place et al., 2008). Computational sequence analysis
predicts that each miRNA can target 10–100s of mRNA transcripts
(Esteller, 2011). In addition, each gene transcript can itself be
targeted by potentially hundreds of miRNAs.
The brain may be a particularly prominent organ within which
miRNAs play an important role in controlling gene expression
and neuronal activity. In a study by Miska et al. it was estab-
lished that there was considerable abundance of miRNAs in rodent
and primate brain (Miska et al., 2004). Further, they developed a
microarray-based method to monitor the spatiotemporal expres-
sion of miRNAs during mouse brain development and found that
there was a dynamic change in miRNA expression levels during
development. As a result of these new methodologies there have
been more than 300 miRNAs identified in adult mouse brain.
Of these brain-enriched miRNAs some are present ubiquitously
whereas others are expressed in a cell specific manner (Bak et al.,
2008).
Another powerful tool that improved our understanding of
the functional relevance of miRNAs in neuronal tissues was the
development of mice with genetic manipulations in the genes
encoding Dicer and Arognaute2 (Ago2). Both of these proteins are
important components of the miRNA biogenesis pathway. Dicer
is an endoribonuclease that catalyzes the processing of precursor
miRNA into its mature form. Characterization of Dicer1 mutants
inC. elegans suggested that this protein plays a critical role in brain
development (Grishok et al., 2001). To assess its role in mam-
malian brain development Bernstein et al. disrupted Dicer in mice
and observed embryonic lethality with depleted number of stem
cells, suggesting that this enzyme is important for development in
general (Bernstein et al., 2003). Subsequently a number of groups
knocked down Dicer via conditional gene targeting, with the find-
ings consistent in demonstrating that ablation of dicer results in
decreased miRNA expression and defects in neuronal cell differen-
tiation and survival (Kanellopoulou et al., 2005; Murchison et al.,
2005; Schaefer et al., 2007). These phenotypes could be rescued by
re-expression of the gene (Kanellopoulou et al., 2005), highlight-
ing the importance for Dicer and the smRNAs species processed
by this endoribonuclease in neuronal development and function.
More recently, conditional deletion of Dicer established that miR-
NAs expressed during neurogenesis play a role in the maintenance
of neural progenitor cells, with disruption in this action contribut-
ing to defects in neuronal migration and subsequently in cortical
lamination (De Pietri Tonelli et al., 2008; Kawase-Koga et al., 2009;
Clovis et al., 2012).
Arognaute2, a member of the argonaute family of proteins,
is the catalytically active component of the RISC that not only
facilitates miRNA processing but also their regulatory actions on
target mRNA transcripts (Hock and Meister, 2008). In a study by
Diederichs and Haber, it was shown that overexpression of Ago2
results in increased miRNA biogenesis (Diederichs and Haber,
2007). Similar to genetic disruption of Dicer, Ago2 deletion results
in embryonic lethality in mice, but conditional knock down of
Ago2 reveals defects in neural tube closure and mispatterning of
the anterior structure of the brain. Mouse embryonic fibroblast
(MEFs) isolated from these mutant mice have reduced miRNA
expression, which can be reversed by Ago2 expression (Morita
et al., 2007). These findings highlight the importance of Ago2 in
neuronal differentiation, brain morphogenesis, and development
(Liu et al., 2004; Morita et al., 2007).
Schratt et al. found that the brain-specific miRNA, miR-134,
is localized to the synaptodendritic compartment and negatively
regulates the size of dendritic spines (Schratt et al., 2006). This
action of miR-134 occurs through its inhibitory action on lim1
kinase expression. Another brain-enriched miRNA, miR-124, has
been shown to play a critical role in the transition of progenitor
neuronal cells to adult neurons by inhibiting networks of non-
neuronal genes, thereby facilitating the expression of the neuronal
identity (Conaco et al., 2006; Makeyev et al., 2007). Aizawa and
colleagues examined the effects of double deletion of miR-9-2
and miR-9-3 on brain development in mice (Shibata et al., 2008,
2011). They found that these miR-9 family members regulate the
proliferation and differentiation of neural progenitor cells in telen-
cephalon through inhibitory actions on regulator proteins impor-
tant for neurogenesis, including the homeobox protein Meis2 and
the transcription factor Forkhead box protein G1 (FOXG1) (Shi-
bata et al., 2008, 2011). Other miRNAs shown to regulate neuronal
lineage commitment include members of the let-7 family and
miR-125b (Leucht et al., 2008; Rybak et al., 2008). More recently,
hippocampus-expressed miRNAs such as miR-134 and miR-34
have been shown to target the deacetylase sirtuin-1 (SIRT1) and
thereby influence learning and memory processes (Gao et al., 2010;
Zovoilis et al., 2011). In addition to their role in neuronal devel-
opment and function, miRNAs may also play key role in neuronal
dysfunction associated neurodegenerative diseases. For example,
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miR-34c has been implicated in the cognitive impairment associ-
ated with dementia. As discussed below, miRNAs have also been
implicated in drug addiction,considered by many to be an aberrant
form of learning and memory.
DRUG ADDICTION AND MicroRNAs
Addiction can be defined as compulsive drug use despite negative
consequences. During the last decade, multiple cellular and mol-
ecular studies have revealed significant convergence between the
actions of drugs of abuse in the brain that drive the development
of addiction and the molecular processes involved in learning and
memory. Indeed, addiction is often conceptualized as a disorder
of synaptic plasticity, and hence the cellular and molecular mecha-
nisms involved in learning-associated synaptic plasticity and con-
comitant remodeling of neuronal circuits may provide an impor-
tant heuristic framework to investigate the addiction process.
In a study by Schaefer et al. it was shown that cocaine-induced
robust alterations in the expression of a wide-range of miRNAs
in the striatum, a key brain site involved in addiction. Indeed,
a subset of these miRNAs whose expression was impacted by
cocaine were shown to regulate the expression levels of a wide-
range of genes known to influence the motivational properties
of cocaine, including Bdnf, FosB (FBJ murine osteosarcoma viral
oncogene homolog B), and Cdk5r1 (cyclin-dependent kinase 5 acti-
vator 1). In the same study, the effects on cocaine reinforcement
of selectively ablating Ago2, the catalytic component of RISC
involved in transducing the inhibitory actions of miRNAs on
their target transcripts, was assessed. Specifically, Schaefer et al.
investigated the effects knocking down Ago2 in medium spiny
neurons (MSNs) of the striatum that express the dopamine D2
receptor (D2R) (Schaefer et al., 2010). Disruption of Ago2 in
D2R MSNs resulted in dramatically reduced conditioned reward-
ing effects of cocaine in mice, reflected in attenuated cocaine-
induced conditioned place preference (CPP). More importantly,
the Ago2-D2R mutant mice also demonstrated reduced intra-
venous cocaine self-administration behavior across a wide-range
of cocaine doses (Schaefer et al., 2010). Such downward shifts in
the cocaine dose-response curve are interpreted as reduced moti-
vation to consume the drug. Finally, Ago2 ablation in D2R MSNs
dramatically decreased miRNA expression and activity in stria-
tum. Hence, as cocaine self-administration behavior is considered
the most direct measure of drug reinforcement in laboratory ani-
mals, these data provide compelling support for a key role for
Ago2, and by extension miRNAs, in striatal MSNs in regulating
the reinforcing properties of cocaine that drive the development
of addiction (Schaefer et al., 2010).
Another interesting study performed by Eipper-Mains et al.
(2011) links cocaine exposure to Ago2 induction (Eipper-Mains
et al., 2011). Characterization of the subcellular fractions of
the striatum shows that Ago2 is localized in synapses and is
cocaine-responsive. Specifically, chronic cocaine exposure resulted
in increased Ago2 mRNA and protein in the striatum, and con-
comitantly altered miRNA expression levels. This increase in Ago2
protein was associated with postsynaptic densities (PSDs) in stria-
tum but not in medial prefrontal cortex (mPFC). Intriguingly,
a large number of cocaine-responsive miRNAs identified so far
(miR-8 family, miR-145, miR-451) can putatively target genes
implicated in addiction, including TrkB receptor, which trans-
duces the actions of BDNF in brain and play a crucial role in
activity-dependent synaptic plasticity.
Chandrasekar and Dreyer identified another set of miRNAs
(miR-181a, let-7d, and miR-124) whose expression is sensitive
to cocaine (Chandrasekar and Dreyer, 2009). They found that
chronic cocaine administration suppressed the expression of miR-
124 and let-7d,but induced miR-181a in the mesolimbic dopamin-
ergic system. The critical role of the mesolimbic dopaminergic
system in addiction is well established (Koob and Volkow, 2010).
In situ hybridization confirmed that the alterations in the expres-
sion of these miRNAs occurred in brain regions related to reward
and memory. Further, in vitro overexpression of these miRNAs
modulated the expression levels of proteins like BDNF and the
dopamine D3 receptor, which have been heavily implicated in drug
addiction (Heidbreder et al., 2005; Ghitza et al., 2010). In a subse-
quent study the same group also showed that in vivo modulation
of these miRNAs in ventral striatum (nucleus accumbens) affects
cocaine-induced place conditioning (Chandrasekar and Dreyer,
2011). These data show that cocaine can impact the expression of
a range of different miRNAs depending on treatment and testing
context, and support an important role for such miRNAs and their
targeted mRNA transcripts in the development of drug addiction.
Alterations in dopamine signaling can lead to long-lasting neu-
ronal adaptations that result in decreased or increased propensity
for drug use. One of the proposed mechanism by which this can
occur is dopamine transmission-induced alterations in the expres-
sion and subunit composition of AMPA receptors (Wolf, 2010).
AMPA receptors are postsynaptic glutamate gated ion channels
that mediate excitatory neurotransmission in the central nervous
system. As such, AMPA receptors are core regulators of synaptic
plasticity and activity-dependent remodeling of brain circuitries
(Du et al., 2004; Haas et al., 2006). In a recent study by Saba
et al. it was found that miR-181a expression in nucleus accumbens
was increased by dopamine-mediated transmission and by the
psychomotor stimulant drugs cocaine and amphetamines (Saba
et al., 2012). Moreover, miR-181a was shown to repress GluA2-
AMPA receptor subunit expression, and thereby modulate the
magnitude of AMPA receptor clustering. Hence, miR-181a may
be a key miRNA involved in drug-induced remodeling of the
nucleus accumbens and greater striatal complex in response to
drug exposure, thereby driving regulating the emergence of addic-
tion. Recent evidence suggests that miRNAs also play a key role in
the actions of other classes of addictive drugs, including nicotine,
alcohol, and opiates; for recent review and detailed table describing
specific miRNAs see Im and Kenny (2012).
THE miR-212/132 CLUSTER
The miR-132/miR-212 family of miRNAs was first identified in
a genome wide search for genes responsive to the transcription
factor cAMP response element binding protein (CREB) using an
approach termed Serial Analysis of chromatin occupancy (SACO)
(Impey et al., 2004). This family of miRNAs is highly conserved
in vertebrates, is transcribed as a polycistronic primary transcript,
and is highly enriched in the mature neurons of the forebrain
(Marson et al., 2008; Hansen et al., 2010). Analysis of the pro-
moter for this miRNA gene cluster reveals the presence of multiple
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FIGURE 1 |The miR-212/132 gene cluster is located on chromosome 17 in humans, 10 in rats, and 11 in mouse. Shown are mouse/human miR-212 and
miR-132 genes, with locations of CRE elements through which CREB can stimulate miR-212 and miR-132 transcription.
cAMP response element (CRE) sites and experimental evidence
verifies that these miRNAs are indeed CREB inducible (Vo et al.,
2005); (see Figure 1) Recent studies from Remenyi et al. have
shown that this gene cluster in fact produces four mature miRNAs,
namely miR-132, miR-132∗, miR-212, and miR-212∗, where miR-
132∗ and miR-212∗ are encoded by the same primary transcript,
but on the opposite strand, as the miR-132 and miR-212 miR-
NAs, respectively (Remenyi et al., 2010). Moreover, each of these
four miRNAs likely have their own unique set of target mRNA
transcripts. Intriguingly, even though these four miRNAs are tran-
scribed in equal measure (by virtue of all being encoded in the
same primary transcript), their relative abundance varies dramat-
ically within various cell types including neurons, with miR-132
being far more abundant than the other three transcripts (Remenyi
et al., 2010). Hence, it is likely that as yet uncharacterized mech-
anisms are involved in preferentially stabilizing miR-132 levels,
and/or destabilizing miR-132∗, miR-212, and miR-212∗.
A series of studies in the last few years have demonstrated the
importance of miR-132 cluster in neuronal morphogenesis and
in regulating synaptic plasticity. In particular, miR-132 has been
shown to increase dendritic spine complexity in both immature
cortical and hippocampal neurons in part by translational inhi-
bition of p250GAP. As p250GAP is a Rho-Rac family GTPase
activating protein, this finding highlights a role for Rho, and
also transducers downstream of Rac-GTPases such as PAK, in
the effects of miR-132 on activity-dependent neuronal remod-
eling (Wayman et al., 2008; Hansen et al., 2010; Magill et al.,
2010).
COCAINE INTAKE AND miR-212
Two recent studies from our group have identified a key role for
miR-212, also encoded by the miR-212/132 gene cluster, in reg-
ulating compulsive-like cocaine intake in rats (Hollander et al.,
2010; Im et al., 2010). As described above, the striatum is a key
brain region that regulates compulsive cocaine use. The first study
showed that in rats with extended access to cocaine (6 h per day)
there is a ∼1.75-fold increase in both striatal miR-212 and miR-
132 levels (Hollander et al., 2010). Similar increases in expression
were not detected in rats that received non-contingent cocaine
infusions time-locked to rats that volitionally consumed cocaine,
or in rats with restricted access to cocaine (1 h per day). Fur-
ther, lentivirus-mediated overexpression of miR-212 in the dorsal
striatum resulted in a remarkable decrease in cocaine intake in
the extended access rats compared to vector control, but overex-
pression did not alter cocaine intake in rats with restricted drug
access (Figure 2). The decreased cocaine intake is related to a
profound decrease in the motivational properties of the drug, as
reflected by a large downward shift in the cocaine dose-response
curve in the same animals. Conversely, inhibition of miR-212
signaling in the striatum, achieved by infusion of an antisense
oligonucleotide, dramatically increased the motivational proper-
ties of cocaine in rats with extended, but not restricted, access to
the drug (Figure 2). These data suggest that intrinsic or drug-
induce alterations in the expression or activity of striatal miR-212
may influence vulnerability to addiction in human cocaine users.
miR-212 REGULATES COCAINE INTAKE THROUGH STRIATAL
CREB SIGNALING
As noted above, expression of miR-212 is regulated by CREB.
In many cases, miRNAs have been shown to influence signaling
cascades that increase their expression and further modify the
activity those cascades through positive or negative feedback
mechanisms (Tsang et al., 2007). As CREB overexpression in
ventral striatum is known to diminish the motivational proper-
ties of cocaine (Carlezon et al., 1998), we tested the hypothesis
that miR-212 may regulate cocaine intake in extended access rats
by amplifying striatal CREB activity through positive feedback
mechanisms. Consistent with a profound stimulatory effect of
miR-212 on CREB in cultured cells in vitro, we found that levels of
CREB that was phosphorylated at serine 133 (i.e., activated CREB)
was significantly increased (Hollander et al., 2010). Furthermore,
forskolin-stimulated expression of the CREB-responsive gene fos
was also increased by miR-212, as was the activity of a luciferase-
based CREB reporter construct (CRE-containing element from
promoter of EVX-1). Dominant negative or phosphorylation-
deficient mutant forms of CREB attenuated these stimulatory
effects of miR-212 on CREB signaling. More importantly, we
also found that miR-212 amplified CREB signaling in the stria-
tum in vivo. Specifically, we found that rats with extended access
to cocaine showed increased expression of the CREB-responsive
gene Nurr1, and that expression levels were greatly increased by
miR-212 overexpression in striatum (Hollander et al., 2010).
These findings identify miR-212 as a novel cocaine-responsive
gene that is up regulated in the striatum in response to cocaine
overconsumption that serves to promote CREB activity through
positive feedback and thereby attenuate the motivational prop-
erties of the drug. Based on these findings, we next investigated
the mechanisms by which miR-212 may amplify CREB signaling.
We found that miR-212 increases activity-dependent production
of cAMP by sensitizing adenylyl cyclase activity. This stimulatory
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FIGURE 2 | Overexpression of miR-212 in striatum reverses the
motivational properties of cocaine in rats with extended but not
restricted access to cocaine. (A) Striatal miR-212 overexpression reverses
the long-term trajectory of cocaine-taking behavior in rats with extended
access. (B) Disruption of miR-212 signaling in striatum, achieved by local
infusion of a locked nucleic acid (LNA) modified antisense oligonucleotide
against miR-212 (LNA-antimiR-212) increases cocaine intake in extended
access. Reproduced with permission from (Hollander et al., 2010).
action on adenylyl cyclase results in accumulation of phosphory-
lated CREB and increased activity of the core CREB co-activators
CREB-regulated transcription co-activator-1 and -2 (CRTC1 and
CRTC2), also known as TORC1 and TORC2. Further investigation
of the mechanism by which miR-212 enhances CREB signaling
revealed that the kinase Raf1 was activated by miR-212, and was
found to play a key role in sensitizing adenylyl cyclase activ-
ity. Finally, computational and biochemical analysis showed that
Sprouty-related EVH1 domain-containing protein 1 (SPRED1), a
known negative regulator of Raf1 signaling, is a miR-212 target
mRNA transcript and SPRED1 repression by miR-212 contributes
to its stimulatory effects on Raf1 and CREB activity (Hollander
et al., 2010).
To investigate the functional relevance of miR-212-induced
amplification of CREB activity in vivo on the suppressive effects
of this miRNA on cocaine intake, we examined the effects of over-
expressing the CREB co-activator CRTC1 (TORC1) on cocaine
intake in rats with restricted or extended cocaine access. It is
known that CRTC overexpression increases CREB activity and
that miR-212 increases CRTC1 expression (Hollander et al., 2010).
Consistent with an important role for striatal CREB signaling
in attenuating the motivational properties of cocaine, we found
that striatal TORC1 overexpression decreased cocaine intake in
extended but not restricted access rats. These findings support the
hypothesis that miR-212 controls cocaine intake at least in part by
amplifying the CREB-TORC signaling axis in striatum. Moreover,
these findings provide compelling support for a key role for miR-
212 in regulating the development of compulsive drug taking in
rats, and perhaps in influencing vulnerability to cocaine addiction
in human drug users.
miR-212 ALSO REGULATES COCAINE INTAKE THROUGH
STRIATAL MeCP2
Considering that miR-212 expression levels may play a key role
in regulating vulnerability to cocaine addiction, we next inves-
tigated the mechanisms by which baseline and cocaine-induced
increases in striatal miR-212 levels are regulated. Interestingly,
sequence analysis of the miR-212/132 gene cluster reveals that it
is located in a CpG enriched region, which can serve as substrate
for DNA methylation and gene regulation. Methyl CpG binding
protein 2 (MeCP2) is known to bind to methylated DNA and can
act as a gene repressor by recruiting other chromatin remodeling
proteins that combine to form the so-called repressor complex
(Guy et al., 2011). Based on these observations, we hypothesized
that MeCP2 may regulate baseline and cocaine-induced changes
in miR-212 expression in striatum and thereby influence cocaine-
taking behavior. Consistent with this hypothesis, in vitro stud-
ies showed that knockdown of MeCP2 increased miR-212 (and
miR-132) expression in cultured cells (Im et al., 2010). Similarly,
pharmacologically induced disruption of DNA methyltransferase
activity, which would be expected to attenuate the inhibitory activ-
ity of MeCP2 on gene expression, also increased miR-212/132
levels. Furthermore, we found that knockdown of striatal MeCP2
expression, achieved by virus-mediated delivery of a short hairpin
interfering RNA (shRNA) against MeCP2, resulted in profoundly
decreased cocaine intake in rats with extended but not restricted
access to cocaine (Figure 3). Knockdown of striatal MeCP2 dra-
matically increased the stimulatory effects of self-administered
cocaine on striatal miR-212 expression in rats with extended but
not restricted access to the drug. More importantly, disruption of
striatal miR-212 signaling, achieved by striatal infusion of an anti-
sense oligonucleotide, reversed the inhibitory effects of MeCP2
knockdown on cocaine intake in extended access rats (Im et al.,
2010). These findings are consistent with an inhibitory effect of
MeCP2 on miR-212 expression, suggesting that MeCP2 acts as a
pro-addiction transcriptional repressor that, by attenuating miR-
212 expression in response to cocaine, increases vulnerability to
addiction.
Intriguingly, miR-132 was previously shown to repress the
expression of MeCP2 through direct interaction with the tran-
script 3′UTR (Klein et al., 2007). Moreover, as miR-132 and
miR-212 share the same seed region, this suggests that miR-
212 may similarly repress MeCP2. Based on these observations,
we hypothesized that in addition to the inhibitory effects of
MeCP2 on miR-212 expression described above, MeCP2 levels
in turn may be repressed by miR-212. In other words, miR-
212 and MeCP2 may be locked in a homeostatic relationship
that serves to control miR-212 expression level and thereby
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FIGURE 3 | Knockdown of MeCP2 in striatum reverses the
motivational properties of cocaine in rats with extended but not
restricted access to cocaine. (A) Lentivirus-mediated knockdown of
MeCP2 in the striatum reverses the escalating cocaine intake typically seen
in rats with extended access to cocaine. (B) In contract, MeCP2
knockdown does not alter cocaine intake in rats with restricted daily access
to the drug. Reproduced with permission from (Im et al., 2010).
influence vulnerability to cocaine addiction. Consistent with this
hypothesis, we found that miR-212 overexpression profoundly
decreased MeCP2 expression in cultured cells and in the stria-
tum in vivo (Im et al., 2010). Hence, homeostatic interactions
between miR-212 and MeCP2 may determine vulnerability to
cocaine addiction.
ROLE FOR BDNF IN REGULATING THE ACTIONS OF STRIATAL
miR-212 ON COCAINE INTAKE
It has been reported that the levels of MeCP2 are closely related to
those of, BDNF (Chang et al., 2006). However, the complex mech-
anisms by which MeCP2 regulates BDNF levels remain unclear.
BDNF in the striatum is known to increase the motivational prop-
erties of cocaine (Horger et al., 1999; Schoenbaum et al., 2007).
We therefore hypothesized that miR-212-MeCP2 interactions may
regulate cocaine intake by influencing levels of BDNF in stria-
tum. We observed that virus-mediated MeCP2 knockdown or
miR-212 expression (which decreases MeCP2 levels) in striatum
reduced BDNF expression. Moreover, virus-mediated increases in
BDNF expression in striatum increased cocaine intake in rats with
extended but not restricted access. Conversely, disruption of stri-
atal BDNF signaling using a neutralizing antibody reduced cocaine
intake in extended but restricted access rats (Im et al., 2010). These
findings suggest that miR-212-MeCP2 interactions may determine
expression levels of BDNF in striatum, which in turn regulates the
motivational properties of cocaine.
NON-NEURONAL ROLES OF miR-212
Besides playing a critical role in drug-induced neuroplasticity rel-
evant to addiction, there is emerging evidence that miR-212 is
also involved in a host of other biological and pathophysiological
processes. Indeed, miR-212 expression is deregulated in various
cancers and its expression has been correlated to disease progres-
sion. In pancreatic carcinomas it has been shown that miR-212
targets the tumor suppressor retinoblastoma (Rb1) (Park et al.,
2011), whereas the methyl binding protein (MeCP2) seems to be
the main target in some of the gastric tumors (Wada et al., 2010).
Incoronato et al. showed that miR-212 targets phosphoprotein
enriched in diabetes (PED), a wide spectrum anti-apoptotic pro-
tein, and thereby plays an important role in tumor suppression
(Incoronato et al., 2010). In a follow up study the same group also
demonstrated that the expression on miR-212 in lung carcinomas
is regulated by histone modifications (Incoronato et al., 2011).
This suggests that epigenetic mechanisms may play an important
role in regulating miRNA expression in different cancers and other
biological processes.
Besides cancer, miR-212 has also been implicated in regulat-
ing organogenesis by playing a key role in modulating epithelial
stromal interactions (Ucar et al., 2010). In addition, miR-212
expression can be regulated by various hormones, adding another
layer of complexity to their regulation and role in development
and disease (Godoy et al., 2011). Studies from Turrini et al.
reveal that miR-212 may mediate drug resistance by targeting the
ABC efflux transporter (Turrini et al., 2012). Two recent reports
implicate the importance of the miR-132/212 family in cardiovas-
cular development and disorders. In the first study, smRNAs deep
sequencing analysis in vascular smooth muscle cells show that the
miR-132/miR-212 cluster is induced by the hormone angiotensin
II and by targeting PTEN, increases the expression of the gene
MCP1 (Monocyte chemotactic protein 1), a key regulator of car-
diovascular disorders (Jin et al., 2012). In the other study, Ucar
et al. demonstrate that these miRNAs activate calcineurin signal-
ing in cardiomyocytes by targeting the transcription factor Foxo3,
and thus play an important role in cardiac hypertrophy (Ucar et al.,
2012).
CONCLUSION
Taken together, these studies highlight the fact that miR-212
plays a critical role in fine-tuning transcriptional and neuroplastic
responses to drugs of abuse. Specifically, we found that miR-212
can control cocaine intake through two complementary mecha-
nisms: amplifying CREB signaling and reducing MeCP2/BDNF
transmission in striatum.
Since miR-212 and miR-132 share the same seed region it
is widely believed that they target the same mRNAs. How-
ever, only a few putative miR-212/132 targets have been verified
experimentally, which include MeCP2, Rb1and HB-EGF. There
is increasing evidence available now showing that the 5′ and 3′
regions of the miRNAs can form the basis of differential target
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recognition despite having the identical seed region (Brennecke
et al., 2005; Jalvy-Delvaille et al., 2012). There is also a possi-
bility that differential expression or availability of these mem-
bers can also regulate gene expression in a differential manner.
Future studies in this respect could further help in improv-
ing our understanding of how miR-212 and miR-132 regu-
late different neuronal and non-neuronal functions or if these
two miRNAs are functionally redundant? More generally, these
findings highlight the novel role for miRNAs in addiction, and
suggest that other ncRNAs may also play important roles in the
disorder.
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